Close Menu

NIH

The method can be used with isothermal amplification and paper-based readouts to detect infectious disease drug resistance in low-resource areas.

The $2.2 trillion economic stimulus package, aimed at bolstering the economy against the effects of the SARS-CoV-2 pandemic, has been signed into law by President Trump.

The US Senate has unanimously passed a $2 trillion stimulus package to address the coronavirus, the New York Times reports.

The team believes that the project will find genetic factors involved in the development of severe COVID-19 in patients that lack risk factors. 

Seeking an Exemption

According to the Washington Post, an NIH researcher has been stymied in getting an exemption to use fetal tissue to study possible COVID-19 treatments.

In Science this week: sequencing of diverse human genomes gives insight into genetic variation and population history, commentary on data sharing, and more.

The authors of the study noted that these genetic findings could guide better clinical decisions for patients and improve outcomes.

And Then for All

NIH Director Francis Collins describes at Forbes how the agency is working with the Bill & Melinda Gates Foundation to develop gene-based treatments for sickle cell disease and HIV for sub-Saharan Africa.

The US House of Representatives has passed an emergency funding bill to address the COVID-19 outbreak, the New York Times reports.

More than 339,000 people have now consented to be part of the program, and more than 265,000 participants have completed the full program protocol.

Pages

Kelvin Droegemeier, the director of the White House Office of Science and Technology Policy, is the new acting director of the US National Science Foundation.

An opinion piece at the Guardian discusses the state of SARS-CoV-2 testing in the UK.

Wired reports the University of California, Berkeley's Innovative Genomics Institute has transformed itself into a diagnostic lab to run SARS-CoV-2 tests.

In Nature this week: direct-capture Perturb-seq approach for combinatorial single-cell CRISPR screens, potential uses of genome-editing in breeding crops, and more.